Site Members can sign up for company wide alerts
Lawsuit Overview
<p>According to a law firm a securities class action has been filed against Genelabs Technologies, Inc. (Nasdaq: GNLB), its Board of Directors and GlaxoSmithKline PLC (”Defendants”) on behalf of all securities purchasers of Genelabs Technologies, Inc. over the proposed acquisition of Genelabs Technologies, Inc. by GlaxoSmithKline PLC. The shareholders alleges that the prices is ...
You must register (for free) or login to view the entire case.